By Simpa Carter
Founded in 1936 by the nationalizing of a 13 company strong industry, British Sugar now a private PLC annually produces over 1.4 million tons of ingredient sugar in the UK. They are also the sole processor of the UK’s entire beet sugar crop giving them an arguably unfair monopoly over the British sugar industry as a whole. Today the company is part of AB Sugar – one of the largest international sugar corporate conglomerates, which is itself wholly owned by international food, ingredients and retail group, Associated British Foods plc (ABF).
In this article, we will explore the links between British Sugar – a registered private company in the UK – and the current ruling British conservative government.
Over the last few decades, British Sugar has diversified from just producing and processing sugar beet, into creatively utilizing it’s excess and waste energy byproducts to produce a variety of horticultural crops.
In a statement from 2016, Managing Director of British Sugar Paul Kenward said; “Sixteen years ago we realised we could use some of the heat and waste carbon dioxide generated in our Wissington sugar factory to develop a horticultural business. During this time, we have invested in our world‐class facilities and developed our expertise to deliver consistent, high-quality crops season after season” adding that “The decision to switch from tomatoes to marijuana was in part to help treat a ‘debilitating childhood disease”.
The condition that Mr. Kenward was referring to was Dravets syndrome – a rare form of epilepsy that causes severe medication-resistant seizures that begin in the first year of life in an otherwise healthy and happy child. It has been known for many years that Cannabis can greatly help reduce seizures and help manage the most dangerous symptoms of Epilepsy.
British sugar announced on October 25th, 2016 that it had won a contract with the UK-based GW Pharmaceuticals and approval from the British Home Office under license to cultivate cannabis in its 18-hectare greenhouse facility at its Wissington factory in Norfolk.
The main chemical component of the cannabis plant are the Cannabinoids and it is specifically a combination of the Cannabinoids Tetrahydrocannabinol (THC) and Cannabidiol (CBD) which seem to exhibit the most anti-epileptic, antispasmodic, and anti-inflammatory properties. When consumed regularly these Cannabinoids have been shown to reduce the rate of seizures in epileptic patients from hundreds a day to a few a week/month.
Since 2016, British Sugar has been completing three cannabis harvests a year, due to be extracted into the $32,500 a year patented drug Epidiolex – a CBD-based medication prescribed for the treatment of Dravet syndrome and Lennox-gastaut syndrome – two rare forms of epilepsy.
In 2018 GW Pharmaceuticals and its US subsidiary Greenwich Biosciences acquired official permission from the FDA to sell their cannabis medication ‘Epidiolex’ as a Schedule 5 prescription drug. This made them the only company in the world to have a patented FDA-approved cannabis-derived prescription medication.
We begin to see yet another unfair commercial monopoly partially created by the government and for the benefit of the producers and not the consumers begin to emerge.
This move all but guarantees further exploitation of the millions of people still facing the daily stigma, legal harassment, and very real threat of imprisonment for simply trying to treat their illnesses/chronic condition with cannabis-derived products – while pharmaceutical companies continue to make tens of millions of pounds in profit,
Don’t worry if you are a little confused as to how the British government is continuing to regurgitate the party line on Cannabis being a “dangerous street drug with no accepted medicinal value”, while at the same time they’re licensing private multinational corporations to grow hundreds of tons of it in the UK to be exported across the world.
As previously mentioned, Paul Kenward is the managing director at British sugar – although you may not have heard of him, you might be familiar with his wife – Victoria Atkins MP who was elected the sitting MP for Louth and Horncastle in May 2015 and was appointed minister at the home office in 2017 by the then-Prime Minister Theresa May.
The former barrister was appointed Parliamentary Under-Secretary of State Minister for Safeguarding by Mrs. May as she was a hard-line prohibitionist especially on Cannabis and that reflected her warped ideology perfectly.
While this is going on at the home office – in number 10 Downing Street Mrs. May’s husband Phillip May the investment relationship manager for the Capital group investment firm which manages a portfolio worth over $2 trillion – is acting as an unofficial adviser to the Prime Minister. Keep in mind that the Capital group is the same firm that is the majority shareholder in GW Pharmaceuticals – a glaring conflict of interest, no?
Mrs. Atkins had to voluntarily recuse herself in 2018 from speaking for the government on matters about cannabis and drug policy as she felt her husband operating a legal cannabis farm constituted a conflict of interest (another painful conflict of interests) She was quietly removed from being responsible for UK drug policy but remains in her post.
Although Mrs. Atkins was no longer “the voice of the government” when it came to drug policy she still had the power to veto the appointment of Niamh Eastwood to the Advisory Council on the Misuse of Drugs (ACMD) in June 2019 – after the home office advisory panel had previously approved her appointment.
The longtime drug policy reformist and executive director at Release had previously been critical of the government and challenged a lot of the antiquated notions that underpin the continuation of the drug prohibition. An appointment that could have been a real and direct threat to the conservative cannabis cartel.
GW Pharmaceuticals announced in early April 2020 that Epidiolex would be de-scheduled in the United States, meaning that it is no longer a controlled substance and can now be sold from any retail outlet, in any state without requiring permission.
So even with all of this being public knowledge and it is rather well documented by the mainstream media there have still been no real ramifications or legal consequences for the small cabal of Conservative ministers who have and continue to blatantly abused their positions to further the corporate agendas of their husband’s companies – further helping to set back cannabis law reform in the UK by years if not decades.
Ultimately, I believe that the best way to avoid the continuation of this kind of capitalistic, corporate, corruption, and cronyism is to completely and utterly decriminalize Cannabis Sativa L in all her natural forms for everyone to utilize as they see fit.